Global InformationTillman Gerngross information
Tillman Gerngross | |
|---|---|
| Born | November 15, 1963 |
| Known for | Founder of multiple biotech companies |
| Academic background | |
| Alma mater | Technical University of Vienna |
| Academic advisors | Arnold Demain, Anthony Sinskey, JoAnne Stubbe |
| Academic work | |
| Discipline | Bioprocess Engineering |
| Institutions | Dartmouth College |
Tillman Gerngross (born November 15, 1963) is an Austro-American scientist.
He is a professor of bioengineering at the Thayer School of Engineering at Dartmouth College, and an adjunct professor in the departments of biology and chemistry at Dartmouth. Gerngross has been an active inventor and to date his work has resulted in the founding of multiple companies (GlycoFi, Inc., Adimab LLC, Arsanis, Inc., Alector [Nasdaq:ALEC], Avitide, Inc., Amagma, Inc., Ankyra, and Adagio [Nasdaq:ADGI])[1][2] and over a dozen U.S. and international patents.[3][4]
Gerngross was elected a member of the National Academy of Engineering in 2017.
- ^ "Home - Adimab".
- ^ Engineering, Thayer School of. "Tillman U. Gerngross | Thayer School of Engineering at Dartmouth". engineering.dartmouth.edu. Retrieved 2016-09-26.
- ^ "Patent Database Search Results: IN/"gerngross tillman" in US Patent Collection".
- ^ "WIPO Search".